Generate Evidence and Value from Global Healthcare Data
UBC’s Real World Data Analytics software effectively and systematically utilizes real-world healthcare data to provide rapid, reliable insight into the safety and utilization of marketed medications along with trends in healthcare.
Comparator cohorts for pre- & post-marketing studies
Customized database feasibility studies for US and European protocols
SÆfetyWorks® is a validated analytical platform that performs rapid descriptive analyses on Administrative Claims and Electronic Medical Record (EMR) data.
Rapidly answer scientific questions related to Epidemiology, Drug Safety, Pharmacovigilance, and Risk Management without the need for customized programming:
Comorbidity and concomitant medication profiles
Disease incidence and prevalence
Signal Detection – Active drug safety surveillance
UBC Technology | CEWorks
CEWorks® allows users to explore patterns of healthcare use and the associated costs in a user-defined cohort. Results provide information on the healthcare experience for a study population in defined timeframes.
Healthcare researchers can rapidly query large, complex healthcare databases, providing the ability to answer key cost effectiveness questions, such as the impact of a new treatment, burden of illness, utilization by payer plan, trends in healthcare over time, physician specialty and many more.
Retrospective Database Services
UBC’s Real World Data Analytics team provides full service (design through execution) real world evidence (RWE) studies using US and European databases.
Pre- and Post-Approval Research: Supports a product’s unique value proposition and identifies other market opportunities to increase market access
RWE Supports Regulatory Decisions: Regulators are increasingly interested in scientific evidence from RWD when evaluating a product’s safety and effectiveness